TAGLN2 and non-small cell lung carcinoma: In non-small-cell lung cancer, hypoxia-inducible TAGLN2 can promote EMT by activating the IGF1RB/PI3K/AKT pathway, thereby stabilizing Snail1, which functions as an E-cadherin suppressor [36].